Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$UUUU added another 20k shares @ $2.11
1/31/17 Spot #Uranium 2400/2500 USc/Lb U3O8 (+12c,+0.4%)
1/31/17 Spot #Uranium 2400/2500 USc/Lb U3O8 (+12c,+0.4%)
Date:01/30/2017 O=25.10 H=25.10 L=25.10 C=25.10 V=0
http://futures.tradingcharts.com/chart/UX/
Date:01/30/2017 O=25.10 H=25.10 L=25.10 C=25.10 V=0
http://futures.tradingcharts.com/chart/UX/
uranium futures up 1.00
http://data.tradingcharts.com/futures/quotes/ux.html
uranium futures up 1.00
http://data.tradingcharts.com/futures/quotes/ux.html
added another 50k shares today...
Spot #Uranium 2400/2475 USc/Lb U3O8 (+25c,+0.9%)
Spot #Uranium 2400/2475 USc/Lb U3O8 (+25c,+0.9%)
Spot # Uranium 2375/2450 USc/Lb U3O8 (+63c,+2.6%)
Spot # Uranium 2375/2450 USc/Lb U3O8 (+63c,+2.6%)
Yes indeed it is......Baby steps have to start somewhere if market price is to increase.
Spot Uranium Price Steady – Investors Hopeful Trump’s Policies Will Boost Commodity
http://www.economiccalendar.com/2017/01/25/spot-uranium-price-steady-investors-hopeful-trumps-policies-will-boost-commodity/
Spot Uranium Price Steady – Investors Hopeful Trump’s Policies Will Boost Commodity
By Leia Toovey -January 25, 2017 - 21:33 GMT
Spot uranium prices continue to tick higher and are now up by $0.50 per lb. versus the prior week, as there is some good sentiment in the market due the new leadership in the US.
On his campaign trail, Trump promised to boost the US’s energy sector which would include expanding coal and nuclear power usage. This week, Trump issued executive orders just after being sworn in as US president that were in alignment with his campaign promises. While he has yet to move to directly boost the uranium sector, the fact that he is fast-tracking pipeline approval and requiring the use of domestically produced materials is causing some positive spillover into the uranium sector. Perhaps, soon we will hear more on his plans for US nuclear energy
While spot uranium has ticked higher this is not anything to get too excited about because the majority of the uranium market is based on longer-term contracts. Overall, these prices are still weak as the uranium market remains awash with supply with demand is still suffering in the aftermath of the Fukushima disaster. Longer-term, the outlook is much better with dozens of nuclear plants currently under construction and even more in the planning process.
In the US, when it comes to nuclear power, right now the trend has been closures rather than developments. Most of the US’s nuclear reactors were built in the 1960s and 1970s and their licenses are nearing expiration. The US has to decide whether to shut down these reactors or extend their lifespans by other 20-years. While a shutdown would dent uranium demand, with Donald Trump leading the country it is seen as likely that either new nuclear capacity will be built or these reactors’ lifespans will be extended by another 20-years. This would bode well for domestic uranium demand.
http://www.economiccalendar.com/2017/01/25/spot-uranium-price-steady-investors-hopeful-trumps-policies-will-boost-commodity/
H.R.590 - Advanced Nuclear Technology Development Act of 2017
H. R. 590
To foster civilian research and development of advanced nuclear energy technologies and enhance the licensing and commercial deployment of such technologies.
IN THE HOUSE OF REPRESENTATIVES
January 20, 2017
Mr. Latta (for himself, Mr. McNerney, Mr. Fleischmann, Mr. Michael F. Doyle of Pennsylvania, Mr. Hudson, and Mr. Tonko) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To foster civilian research and development of advanced nuclear energy technologies and enhance the licensing and commercial deployment of such technologies.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Advanced Nuclear Technology Development Act of 2017”.
SEC. 2. Findings.
Congress finds the following:
(1) Nuclear energy generates approximately 20 percent of the total electricity and approximately 60 percent of the carbon-free electricity of the United States.
(2) Nuclear power plants operate consistently at a 90 percent capacity factor, and provide consumers and businesses with reliable and affordable electricity.
(3) Nuclear power plants generate billions of dollars in national economic activity through nationwide procurements and provide thousands of Americans with high paying jobs contributing substantially to the local economies in communities where they operate.
(4) The United States commercial nuclear industry must continue to lead the international civilian nuclear marketplace, because it is one of our most powerful national security tools, guaranteeing the safe, secure, and exclusively peaceful use of nuclear energy.
(5) Maintaining the Nation’s nuclear fleet of commercial light water reactors and expanding the use of new advanced reactor designs would support continued production of reliable baseload electricity and maintain United States global leadership in nuclear power.
(6) Nuclear fusion technology also has the potential to generate electricity with significantly increased safety performance and no radioactive waste.
(7) The development of advanced reactor designs would benefit from a performance-based, risk-informed, efficient, and cost-effective regulatory framework with defined milestones and the opportunity for applicants to demonstrate progress through Nuclear Regulatory Commission approval.
SEC. 3. Definitions.
In this Act:
(1) ADVANCED NUCLEAR REACTOR.—The term “advanced nuclear reactor” means—
(A) a nuclear fission reactor with significant improvements over the most recent generation of nuclear fission reactors, which may include inherent safety features, lower waste yields, greater fuel utilization, superior reliability, resistance to proliferation, and increased thermal efficiency; or
(B) a nuclear fusion reactor.
(2) DEPARTMENT.—The term “Department” means the Department of Energy.
(3) LICENSING.—The term “licensing” means NRC activities related to reviewing applications for licenses, permits, and design certifications, and requests for any other regulatory approval for nuclear reactors within the responsibilities of the NRC under the Atomic Energy Act of 1954.
(4) NATIONAL LABORATORY.—The term “National Laboratory” has the meaning given that term in section 2 of the Energy Policy Act of 2005 (42 U.S.C. 15801).
(5) NRC.—The term “NRC” means the Nuclear Regulatory Commission.
(6) SECRETARY.—The term “Secretary” means the Secretary of Energy.
SEC. 4. Agency coordination.
The NRC and the Department shall enter into the a memorandum of understanding regarding the following topics:
(1) TECHNICAL EXPERTISE.—Ensuring that the Department has sufficient technical expertise to support the civilian nuclear industry’s timely research, development, demonstration, and commercial application of safe, innovative advanced reactor technology and the NRC has sufficient technical expertise to support the evaluation of applications for licenses, permits, and design certifications, and other requests for regulatory approval for advanced reactors.
(2) MODELING AND SIMULATION.—The use of computers and software codes to calculate the behavior and performance of advanced reactors based on mathematical models of their physical behavior.
(3) FACILITIES.—Ensuring that the Department maintains and develops the facilities to enable the civilian nuclear industry’s timely research, development, demonstration, and commercial application of safe, innovative reactor technology and ensuring that the NRC has access to such facilities, as needed.
SEC. 5. Advanced reactor regulatory framework.
(a) Plan required.—Not later than 1 year after the date of enactment of this Act, the NRC shall transmit to Congress a plan for developing an efficient, risk-informed, technology-neutral framework for advanced reactor licensing. The plan shall evaluate the following subjects, consistent with the NRC’s role in protecting public health and safety and common defense and security:
(1) The unique aspects of advanced reactor licensing and any associated legal, regulatory, and policy issues the NRC will need to address to develop a framework for licensing advanced reactors.
(2) Options for licensing advanced reactors under existing NRC regulations in title 10 of the Code of Federal Regulations, a proposed new regulatory framework, or a combination of these approaches.
(3) Options to expedite and streamline the licensing of advanced reactors, including opportunities to minimize the time from application submittal to final NRC licensing decision and minimize the delays that may result from any necessary amendments or supplements to applications.
(4) Options to expand the incorporation of consensus-based codes and standards into the advanced reactor regulatory framework to minimize time to completion and provide flexibility in implementation.
(5) Options to make the advanced reactor licensing framework more predictable. This evaluation should consider opportunities to improve the process by which application review milestones are established and maintained.
(6) Options to allow applicants to use phased review processes under which the NRC issues approvals that do not require the NRC to re-review previously approved information. This evaluation shall consider the NRC’s ability to review and conditionally approve partial applications, early design information, and submittals that contain design criteria and processes to be used to develop information to support a later phase of the design review.
(7) The extent to which NRC action or modification of policy is needed to implement any part of the plan required by this subsection.
(8) The role of licensing advanced reactors within NRC long-term strategic resource planning, staffing, and funding levels.
(9) Options to provide cost-sharing financial structures for license applicants in a phased licensing process.
(b) Coordination and stakeholder input required.—In developing the plan required by subsection (a), the NRC shall seek input from the Department, the nuclear industry, and other public stakeholders.
(c) Cost and schedule estimate.—The plan required by subsection (a) shall include proposed cost estimates, budgets, and specific milestones for implementing the advanced reactor regulatory framework by September 30, 2019.
(d) Design certification status.—In the NRC’s first budget request after the acceptance of any design certification application for an advanced nuclear reactor, and annually thereafter, the NRC shall provide the status of performance metrics and milestone schedules. The budget request shall include a plan to correct or recover from any milestone schedule delays, including delays because of NRC’s inability to commit resources for its review of the design certification applications.
SEC. 6. User fees and annual charges.
Section 6101(c)(2)(A) of the Omnibus Budget Reconciliation Act of 1990 (42 U.S.C. 2214(c)(2)(A)) is amended—
(1) by striking “and” at the end of clause (iii);
(2) by striking the period at the end of clause (iv) and inserting “; and”; and
(3) by adding at the end the following:
“(v) for fiscal years ending before October 1, 2020, amounts appropriated to the Commission for activities related to the development of regulatory infrastructure for advanced nuclear reactor technologies.”.
https://www.congress.gov/bill/115th-congress/house-bill/590/text
added another 30k shares @ .76
$UUUU Grabbed a start position......fundamentals look strong for both $UUUU & $URG
Sold $URRE this morning....... Picked up 70k shares $URG
Chinese firm begins testing GMO corn seeds in U.S. greenhouse
A Chinese biotech seed firm has planted genetically modified corn seeds in the United States at a greenhouse designated by the U.S. Department of Agriculture, the company said, an early step toward launching China's first GMO corn products in the United States.
Beijing-based Origin Agritech Ltd said on Wednesday that U.S. field tests of its seeds, with insect resistance and herbicide tolerance technologies developed in China, are scheduled to begin next summer.
The U.S.-listed company is aiming to launch its GMO corn products on the home turf of the world's top agricultural companies, as Beijing's reticence over GMO food keeps the domestic market off limits. t must perform tests to obtain approvals for potential U.S. sales from the USDA, the U.S. Environmental Protection Agency and the U.S. Food and Drug Administration.
Critics of GMO crops believe they contribute to the industrialization of farming and question research showing they are safe for humans.
Origin Agritech's efforts mark the latest move by a Chinese firm to jump into the competitive global biotech seed sector, which has long been dominated in the United States by Monsanto Co and Pioneer, a unit of DuPont.
China National Chemical Corp [CNNCC.UL] has agreed to buy Swiss-based seed and farm chemicals company Syngenta AG, which does business in the United States, for $43 billion.
Also In Environment
The global agricultural sector is scrambling to consolidate, with Monsanto and DuPont also pursuing separate tie-ups, as a global downturn in grain prices and a strong dollar have reduced U.S. farm incomes and prompted producers to cut spending.
http://www.reuters.com/article/us-origin-agritech-gmo-usa-idUSKBN1442OP
ORIGIN AGRITECH: A CALL OPTION ON CHINA GOING GMO POSITIVE?
We think so!
Upgrading Shares from Buy to Strong Buy
PRICE TARGET $10
Symbol: SEED
Price: $2.47
Shares Outstanding: 22.8 million
Float: 17.55 million
Cash: ~$35 million
Debt: ~$14 million
TRUMP SELECTS IOWA-R GOVERNOR TO BE US AMBASSADOR TO CHINA
Last week, President-Elect Trump selected Terry Branstad the Governor of Iowa-R to be the US Ambassador to China. This is a tremendous asset to not only agriculture stocks, but to our bullish thesis on Origin. In fact, The Washington Post reports Branstad was just in China last month visiting with China’s Ministry of Agriculture (MOA) and other officials. We believe, Origin heads could have been involved in some of those gatherings as the company officials said they spent 2 weeks in China in early November. Coincidence we think not. In concert, Bill Niebur, the CEO of Origin continues to devote his time to bring China – US relations closer through agriculture. Remember, in 2015, he was awarded One of 50 People Shaping the Future of the U.S.-China Relationship. As a result, at this valuation we see this announcement as big as any future deals Origin may forge in the weeks to months to come.
On the heels of the optimal selection of Branstad, we’re upgrading the shares concluding the first introduction of Origin’s new senior management team to Wall Street. This new team consists of CEO Dr. William Niebur, an ex-Dupont only executive of 33 years, CFO Sharshank Aurora, an ex-Dupont executive of 25 years and CTO Dr. Jihong Liang, an ex-Syngenta & ex-Monsanto head of R&D. Combined, the team possesses the cultivation and harvesting of the next breeding grounds in Big Ag growth. During the visit, Origin presented its 3 Pillars of Growth: China Biotech, Global Biotech Traits and Non-GMO/Organic (E-Commerce Platform) which we see being 3 pillars with high barriers to entry. This distinguished team brings a lengthy olive branch within the top global agriculture companies making Origin a call option on igniting China’s effort in becoming GMO positive and an equal in the global agriculture world.
In our view, the master plan at Origin is to clean house reinforcing and bringing to market its biotech arsenal (12 years of government GMO trait trials) and its unique broad germ plasm bank via an ultra attractive subscription fee royalty model with both Chinese national companies and Multi-national seed companies. This past September, the new Origin team (150 days on the job), announced that it would sell its commoditized seed business for what amounts to be well over $60 million over the life of the deal. This maneuver, unquestionably makes Origin an attractive biotech company in agriculture. They’re about to provide the wow factor to investors and traders alike whenever it executes on its planned roadmap.
We maintain our bullish stance and believe the market has yet to fully value the company’s tangible and intangible assets. Furthermore, in our opinion, the market is oblivious to the importance of China wanting to become an agriculture equal in the global marketplace. In total, the company is addressing a $4.7 billion total available market with most of that revenue being derived from fees which carry very high gross margins. The shares are one or two events away from uncovering the tremendous upside that resides inside of China and outside of China over the next 1-3 years in this under appreciative company.
We, continue to rate shares a buy with a price target of $10 or ~$230 million market capitalization in the next 12 months and a price target of $15 or ~$370 million market capitalization on China lifting its GMO ban. By looking at the charts, the team, the total available market, the attractive subscription based business model, Branstad selection and the ambitions of China it’s only a matter of time before the market starts to recognize the value never mind appreciate it. Our price target reflects that process.
OUT WITH THE OLD IN WITH THE NEW
Late September, the company unexpectedly announced it sold its seed business for $60 million in cash and royalties on current and future portfolio products. In addition, the acquiring company will pay for subscriptions on Origin’s pipeline of new products. We calculate the deal being worth $70 million dollars over a 3-4 year period. The deal allows the company to fully maintain all its IP and government trials on GMO traits and to remove itself from the fluctuations of the commoditized seed business, a time consuming fight for scraps. Conversely, it extends its financial runway to an international runway and it opens the door for the company to be fully focused on being a pure play agriculture biotech to not only China, but the rest of the world. It also gives a seasoned and diversified agriculture team the room to run with the ball and utilize both its biotech & business creativity, contacts and vision it accumulated during the combined 83 years at top executive positions in the three biggest Ag companies of the world. Who better to make this happen? As Neibur explained to Benzinga. “What we have done is that we’ve tried to position ourselves in a way to develop novel routes to market in some of these novel, emerging, fast-growth markets, albeit from a small base, but fast growth nonetheless”. We applaud this move with great fanfare and see this move as transparent and transcendent in its effort to be the first Chinese micro-cap to outlandishly pilot itself to multi-national status. A massive task, but it already has multinational backing in its executive team, its IP, its strategic partner Dupont and the relationship Branstad has with China to catapult off of.
PROOF IT’S CLEAN AND TRANSPARENT
Prior to selling the seed business Origin’s Chairman and founder Doctor Han, set out to pass his 18 years of building a solid agriculture biotech platform to a more acclimated group of confident, trusted executives to grow the value of these unrecognized assets. He also recently decided to take permanent residence in the US by buying a home in the past year. We view his residency as a big showing of credibility and transparency in the integrity of Origin’s corporate structure. For us, this is one Chinese company we feel that what you see is what you get. A hard statement to say never mind put in print. When you place an executive such as Niebur in the CEO cockpit after spending his entire career at one blue chip company, you know the due diligence has been thoroughly done. Add the current CFO, Sharshank Aurora, having spent 25 years at Dupont and most likely being a conservative, reserved risk controlled person by nature of his occupation, we see even further proof Origin is one micro-cap company with all the transparency of a US company with all the upside to China’s demographics. Last but not least, the Chinese American CTO Jihong Liang’s having been head of R&D at Monsanto and Syngenta makes his acceptance of the position as CTO further proof Origin has technical merit. We see this as four of a kind.
BREEDING BEST OF BREED MANAGEMENT
We believe the company will have the opportunity to hand pick the best of breed scientists inside and outside of China, as well as legal counsel, business development and marketing heads as the recent wave of consolidation in the agriculture industry will attract talent that see the inherent financial leverage in this team, demographics and technology. We believe that the CEO said it best in a recent interview with Benzinga. “We feel like we’ve assembled diversity in the sense of where we’ve come from and where we’ve developed, but also who we’ve worked with, but we have a common understanding of what it’s like to operate at the highest levels of science and the highest levels of business and transparency and ethical behavior within the company,”
CHINA IS READY TO ROCK AND ROLL ON GMO
In August and September, China’s government made two historic announcements that have gone unnoticed by most investors, but noticed by many different media outlets. First, the Chinese government announced in its 13th “Five Year Plan” that it will be lifting its GMO ban in the next 2-3 years. This is an absolute first! We already know China backed ChemChina’s $43 billion dollar bid for Syngenta (SYT) earlier this year. A first by China in the agriculture industry. However, if you talk to people familiar with China then you know that when the Chinese decide to do something they do it fast. It’s taken a long time for the government to publicly act on lifting the GMO ban, but now we get the chance to witness just how fast it’ll catch up to global levels. In Chinese fashion, it showed its hand just a few weeks post announcing its intentions to lift the ban. It allocated $450 billion towards agriculture spending over the next four years. We believe Origin could be behind some of these assets when its turn comes. In fact, the Chinese government could be providing the financing for the acquiring company of Origin’s seed business which if true is a clear sign how important it sees Origin’s biotech arm being as they attempt to become the first Chinese multinational from micro-cap scale. The Chinese government is not done making noise in its effort to feed its country independently and also be known as a global participant in the field of agriculture science.
3 PILLARS OF GROWTH
CHINA BIOTECH
Origin now has ample funds to accelerate its biotech arm of GMO traits and germ plasm library. In addition, it will position itself as a “no brainer” ally to both local seed companies and more importantly, multinational seed companies (MNCs) that need competent, trustworthy Ag personnel and technology coverage in China. That personnel, will be handpicked, best of breed affording MNCs parallel caliber R&D at good value and a local respected arm for navigation through China’s rigid regulatory system for foreign entities that have to participate in China’s Ag business to grow. For example, Dupont, a 12-15% market share leader in China, licensed Origin’s IP in early 2016 exclusively for China only which we believe could be extended to other countries in the near future. This relationship is certain to open dialogue with the other MNCs and in fact we heard management is in discussions with 2 other parties that are unknown.
We remind investors that in 2009 China granted Origin’s R&D efforts to bring Phytase corn from phase I – Phase V with China’s first GMO approval rating. The shares exploded from $4 per share to $15 per share. In that time, Fidelity initiated a 10% stake in the company. Unfortunately, China wasn’t in a GMO positive mode like it is today. A big difference for the new Origin when the company gets its next GMO trait through the approval process.
From our sources, during the NDR, Origin stated that it recently submitted its Weed Resistant GMO trait (GT) for Chinese government approval. We find this to be material and significant to the value of Origin’s share price, as it creates a more significant price move if and when it receives approval. To be clear, no one knows if and when China will approve the trait but we believe more than ever, China will be more proactive on GMO activities after proclaiming its positive stance in August.
From its presentation deck (slide 11), Origin estimates the Chinese GMO traits market to be worth an estimated $1 billion in licensing fees. We believe Origin’s 2 licensees total a minimum of 15% market share of the Chinese seed market and could represent over 20-25% over the next 1-2 years prior to China going GMO positive by 2019. To achieve 20-25% levels management would need to close more strategic partners. That could total $150,000,000 – $250,000,000 in royalties. This estimate is based on China becoming 90% GMO just like North America and it would of course take many years post being approved. We remind investors that licensing business models fetch up to 10x sales in valuation from investors. Our $15 target or $370 million valuation is less than 3x our low end revenue estimate of $150 million dollars.
We don’t see another Nasdaq traded company in the agriculture space or outside it with the ability to garner strategic partnerships with Fortune 500 companies via equity upfront, licensing fees or other creative financial maneuvers in an untapped market the size of feeding China with a management team fit to run a MNC at only a $50 million market capitalization. To us, this pillar exemplifies high barriers to entry.
GLOBAL BIOTECH TRAITS
Origin has submitted documentation to Chinese officials to become the first company to ever receive approval to export GMO traits and germ plasm outside the country. Upon this approval, the company will seek out top multinational Ag companies (MNCs) to license its much more cost effective biotech traits and germ plasm. The company has submitted the proper documentation to receive governmental approval to export the traits to kick off this pillar. This approval, will give Origin great bargaining power in forming strategic partnerships for pillar #1. This announcement could be what breaks the stock out of micro cap status and we believe this approval is highly probable as the Chinese government holds Dr Han and his team in very high regard in supporting their global expansion in agriculture biotech. It could be why Branstad was visiting the MOA in Beijing last month too. This approval will make Origin the only Chinese company to have this authorization which furthers the high barriers to entry formula in pillar 2.
NORTH AMERICA NON-GMO/ORGANIC
This pillar brings two new unexpected opportunities to Origin. It also could be the first glimpse into the creativity and innovative minds at the helm. Certainly, entering the organic markets will be unique to Origin, but it also allows us to witness how the minds at work operate. In addition, the team wants to develop an E-commerce platform in the non GMO and organic space to make the process from producers of the seeds to the end users more functional and transparent which the management team believes it can do with ingenuity and foresight in what it sees as a $1.2 billion addressable market. We all know how Amazon handled the retail world and from our sources the company believes it can be the Amazon of the seed market. This is unique, exciting, unexpected and any deals that are signed or aligned in this area will unfold a potential high barriers to entry model. This has equity stake potential in an effort to raise funds and spin-off potential further down the road.
KEY CATALYSTS
These are some of the key events we place a high probability of occurring in the next 1-6 months:
China approving its new GMO trait submission to the MOA for approval. China is being pushed to get off the starter’s block. This would be game changing and its now submitted and waiting approval at anytime.
A US big Ag or a Chinese company acquires Origin for $8+ per share.
Top agriculture heads are elected to the board of directors.
Announcing E-commerce partners.
A prominent person or company takes an equity stake in the E-portal.
Receiving approval by the Chinese Government to be the first company to export GMO seed traits and/or germ plasm to the United States. A first step in the company being able to become a multinational in the seed industry. A key event.
Announcing key partnerships with one or more of the big 6 agriculture companies in its expansion into the US, Latin America and EMEA. They include but not limited to: MON SYT DD KWS RKDA
Receiving non-dilutive funding from a wealthy industry veteran, a private entity and/or big Ag in what could be a defining moment for the new Origin.
An institutional holder becomes a 5-10% holder in the shares of SEED.
China kicking off a pro GMO media campaign.
China spending some of its $450 billion earmarked for agriculture biotechnology spending that gains the attention of the global media and Wall Street.
In summary, Origin has one GMO trait approved for commercialization in China (2009 renewed 2013) that created $230 million in market value($4-$15) in a few short weeks, It has one trait for weed resistance (GT) that has been submitted for approval (2016) that under the Chinese government’s first publicly pro GMO stance should create at least ~$270 million in market value($15) and it has 2 other traits in phase II and phase III of a five phase process. Each phase is a planting season (1 year), so the first two traits approved and in submission equals 10 years of R&D by both Origin and the Chinese academy of Agriculture Science (CAAS). That has a tangible cost and an intangible value once GMO is a go in China or granted approval to export from China. Moreover, the company possesses a germ plasm library that is deep and potent for immediate licensing. These traits and germ plasm coupled with the company’s position with the ministry of agriculture (MOA) in China presents real tangible and intangible value way beyond today’s net enterprise value of ~$25 million. The management team alone could be valued at $50-100 million if focused on more intently by the buy and sell sides. That value could surface overnight if any future coverage by analysts and/or strategic deals come to fruition or investors are ready to harvest their due diligence like we have.
Origin, just buttoned up a 2 week NDR going through NYC, Boston and Chicago. It also attended the ASTA conference in Chicago where a who’s who of the seed world came together to have meetings of the minds (seeds). Furthermore, the unexpected simultaneous selection of Branstad should allow for optimism in the new Origin’s game plan. This could be the ground floor entry point for new investors with big purchasing power and for all types of other investors if this team has any of the above catalysts we highlighted or others we haven’t brain trusted on. We like it better in the $2.50 range than the $1.71 range back in June when we initiated coverage. This could be one bullish call that brings call option returns.
https://eximiuscapitalgroup.wordpress.com/2016/12/12/origin-agritech-a-call-option-on-china-going-gmo-positive/
Interesting speculation from Niels Hoej Docket #1823
https://cases.primeclerk.com/sunedison/Home-DocketInfo
SunEdison Must Respond to Shareholder Claims of Newfound Riches
Posted on December 6, 2016
(Bloomberg) — SunEdison Inc. was ordered to answer allegations that its value has increased since it filed for bankruptcy and that there could be something left for shareholders after the renewable-energy company’s creditors get paid.
U.S. Bankruptcy Judge Stuart Bernstein told SunEdison lawyers Tuesday in Manhattan to respond to the claims. The company must show whether it has indeed gotten “rich” while in bankruptcy because of rising equity values, he said, citing a shareholder e-mail.
SunEdison’s stakes in its two yieldcos, TerraForm Power Inc. and TerraForm Global Inc., have increased in value to around $3 billion, and the company can also use $2.3 billion in net operating losses to offset future tax liability, Rafael Hernandez said in a Dec. 2 e-mail filed in Bernstein’s court.
Those factors, along with others, mean shareholders may now be in the money, Hernandez said.
Lawyers for Maryland Heights, Missouri-based SunEdison, which filed for bankruptcy April 21, didn’t immediately return calls for comment
In U.S. bankruptcies, shareholders can’t collect anything unless other creditors have been paid off. SunEdison’s have been fighting to recover billions in equity value they say was lost as a direct result of fraud by the company’s officers and directors. They’re seeking to participate in the mediation of similar claims made by unsecured creditors and have sent dozens of letters to Bernstein asking to form a committee to pursue recoveries.
‘Hopelessly Insolvent’
In August, Bernstein denied their initial request, saying the shareholders had failed to show the company wasn’t “hopelessly insolvent.” He left the door open, however, saying that “if facts change, the shareholders can renew their motions.”
They have since pleaded with the judge to reconsider.
Bernstein recently approved the formation of an equity committee in the case of Breitburn Energy Partners LP, after shareholders said the bankrupt company was low-balling its own valuation.
Hernandez said that he and a group of 850 other shareholders have legal counsel and intend to bring a formal motion for an equity committee soon.
His e-mail is addressed to the U.S. Trustee, the Justice Department’s bankruptcy watchdog. In it, Hernandez said he’s among shareholders who bought SunEdison stock in the belief that renewables can compete with fossil fuels. Now they want a seat at the table with the company’s lenders and unsecured creditors as a bankruptcy plan is negotiated. The U.S. Trustee hasn’t responded to the request, Hernandez said in the e-mail.
TerraForm Power’s shares, which traded at around $10.46 the day SunEdison filed for bankruptcy, closed at $12.56 Monday.
TerraForm Global, $2.99 at the start of the bankruptcy, closed at $3.80 Monday. SunEdison has called its holdings in the two yieldcos its most valuable assets.
“Facts show that SunEdison no longer appears ‘hopelessly insolvent’ and there is some distribution available for shareholders,” Hernandez wrote.
http://distressions.com/sunedison-must-respond-to-shareholder-claims-of-newfound-riches/
Nice volume......sold half my position today, still holding 35k shares.
just a small head fake A/H..... 25 shares $2.85 then 75 shares at $2.95 then 2000 shares @ $2.71
manipulation I'm sure.....
$SEED baby steps past few days.....
$SEED somethings up besides the price.....Lol.
I agree! simply brilliant..... perhaps we can break the psychological $2.50 a share price today.
This is a good thing $SEED is clearly going higher in coming weeks......
This wont stay down for long Imo. much growth potential in China with a micro float share structure.....China to invest $450 billion in agriculture Over the next four years.
http://2ruth.net/2016/09/china-to-invest-450-billion-in-agriculture-and-gmo039s/
Perhaps someone knows something, or is just a gambler..... bottom line is only $8300 dollars traded today. volume always proceeds price so hoping for the best here
Looks like it was 2 to 1 sells over buys.....I'm sure someone lost a load of cash.
http://ih.advfn.com/stock-market/USOTC/bio-amd-inc-qb-BIAD/trades
If it were me I'd wait until the end of December.....you just never know with penny stocks. could be a huge surprise coming "not optimistic" but just saying....
you could say that again......Lol.
expected see $4.00 a share with such a small float
Gap filled time to move North again
That's the way I see it......should have sold @ 25 cents, guess I was being greedy......Lol.
Haven't sold any shares of BIAD.... If I did It would be in December.
Management should be proud of their achievements here.....